vs

Side-by-side financial comparison of EXPONENT INC (EXPO) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

EXPONENT INC is the larger business by last-quarter revenue ($166.3M vs $93.1M, roughly 1.8× HIVE Digital Technologies Ltd.). EXPONENT INC runs the higher net margin — 17.8% vs -98.1%, a 115.9% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 14.3%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 8.8%).

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

EXPO vs HIVE — Head-to-Head

Bigger by revenue
EXPO
EXPO
1.8× larger
EXPO
$166.3M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+204.3% gap
HIVE
218.6%
14.3%
EXPO
Higher net margin
EXPO
EXPO
115.9% more per $
EXPO
17.8%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
8.8%
EXPO

Income Statement — Q1 FY2027 vs Q3 FY2026

Metric
EXPO
EXPO
HIVE
HIVE
Revenue
$166.3M
$93.1M
Net Profit
$29.6M
$-91.3M
Gross Margin
-27.1%
Operating Margin
24.9%
Net Margin
17.8%
-98.1%
Revenue YoY
14.3%
218.6%
Net Profit YoY
11.0%
-234.0%
EPS (diluted)
$0.59
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPO
EXPO
HIVE
HIVE
Q1 26
$166.3M
Q4 25
$147.1M
$93.1M
Q3 25
$142.0M
$87.3M
Q2 25
$145.5M
$45.6M
Q1 25
$136.8M
Q4 24
$29.2M
Q3 24
$136.3M
$22.6M
Q2 24
$140.5M
$32.2M
Net Profit
EXPO
EXPO
HIVE
HIVE
Q1 26
$29.6M
Q4 25
$28.0M
$-91.3M
Q3 25
$26.6M
$-15.8M
Q2 25
$26.6M
$35.0M
Q1 25
$23.6M
Q4 24
$68.2M
Q3 24
$26.0M
$80.0K
Q2 24
$29.2M
$-18.3M
Gross Margin
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
-27.1%
Q3 25
4.7%
Q2 25
-13.6%
Q1 25
Q4 24
-43.7%
Q3 24
-66.1%
Q2 24
-7.4%
Operating Margin
EXPO
EXPO
HIVE
HIVE
Q1 26
24.9%
Q4 25
19.7%
Q3 25
12.1%
Q2 25
30.5%
Q1 25
19.9%
Q4 24
Q3 24
19.0%
Q2 24
25.4%
Net Margin
EXPO
EXPO
HIVE
HIVE
Q1 26
17.8%
Q4 25
19.1%
-98.1%
Q3 25
18.7%
-18.1%
Q2 25
18.3%
76.8%
Q1 25
17.2%
Q4 24
233.2%
Q3 24
19.1%
0.4%
Q2 24
20.8%
-56.7%
EPS (diluted)
EXPO
EXPO
HIVE
HIVE
Q1 26
$0.59
Q4 25
$0.55
$-0.38
Q3 25
$0.52
$-0.07
Q2 25
$0.52
$0.18
Q1 25
$0.45
Q4 24
$0.52
Q3 24
$0.50
$0.00
Q2 24
$0.57
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPO
EXPO
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$118.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.3M
$559.3M
Total Assets
$687.4M
$624.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPO
EXPO
HIVE
HIVE
Q1 26
$118.6M
Q4 25
$207.4M
Q3 25
$231.8M
Q2 25
$245.1M
Q1 25
$258.9M
Q4 24
$40.5M
Q3 24
$219.7M
$31.7M
Q2 24
$203.3M
Stockholders' Equity
EXPO
EXPO
HIVE
HIVE
Q1 26
$338.3M
Q4 25
$402.9M
$559.3M
Q3 25
$427.8M
$624.6M
Q2 25
$441.4M
$560.5M
Q1 25
$421.1M
Q4 24
$430.9M
Q3 24
$410.3M
$275.5M
Q2 24
$393.2M
$268.6M
Total Assets
EXPO
EXPO
HIVE
HIVE
Q1 26
$687.4M
Q4 25
$761.4M
$624.0M
Q3 25
$759.4M
$693.0M
Q2 25
$763.2M
$628.7M
Q1 25
$777.3M
Q4 24
$478.6M
Q3 24
$744.1M
$334.7M
Q2 24
$709.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPO
EXPO
HIVE
HIVE
Operating Cash FlowLast quarter
$46.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
$32.7M
$46.0M
Q3 25
$36.2M
$-10.6M
Q2 25
$7.3M
$10.2M
Q1 25
$56.1M
Q4 24
$-28.5M
Q3 24
$29.7M
$-2.2M
Q2 24
$48.3M
$-4.4M
Free Cash Flow
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
$30.0M
Q3 25
$33.9M
Q2 25
$5.5M
Q1 25
$53.5M
Q4 24
$-55.5M
Q3 24
$28.0M
$-34.7M
Q2 24
$47.2M
FCF Margin
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
20.4%
Q3 25
23.9%
Q2 25
3.8%
Q1 25
39.1%
Q4 24
-189.9%
Q3 24
20.5%
-153.4%
Q2 24
33.6%
Capex Intensity
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
1.8%
Q3 25
1.6%
Q2 25
1.2%
Q1 25
1.9%
Q4 24
92.5%
Q3 24
1.3%
143.9%
Q2 24
0.8%
Cash Conversion
EXPO
EXPO
HIVE
HIVE
Q1 26
Q4 25
1.16×
Q3 25
1.36×
Q2 25
0.27×
0.29×
Q1 25
2.38×
Q4 24
-0.42×
Q3 24
1.14×
-26.94×
Q2 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

HIVE
HIVE

Segment breakdown not available.

Related Comparisons